Albemarle (NYSE:ALB) Sets New 52-Week High After Analyst Upgrade

Albemarle Corporation (NYSE:ALBGet Free Report)’s share price hit a new 52-week high on Wednesday after BMO Capital Markets raised their price target on the stock from $136.00 to $145.00. BMO Capital Markets currently has an outperform rating on the stock. Albemarle traded as high as $137.94 and last traded at $138.4950, with a volume of 625106 shares. The stock had previously closed at $131.07.

Several other research firms have also recently issued reports on ALB. Rothschild Redb upgraded shares of Albemarle to a “strong-buy” rating in a report on Friday, October 24th. Robert W. Baird set a $113.00 target price on shares of Albemarle and gave the stock a “neutral” rating in a research report on Tuesday, December 2nd. Baird R W upgraded shares of Albemarle from a “strong sell” rating to a “hold” rating in a research note on Tuesday, December 2nd. Citigroup upped their target price on Albemarle from $95.00 to $100.00 and gave the stock a “neutral” rating in a research report on Friday, November 7th. Finally, Jefferies Financial Group boosted their price objective on Albemarle from $124.00 to $152.00 and gave the stock a “buy” rating in a research report on Monday, December 8th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, eighteen have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, Albemarle currently has a consensus rating of “Hold” and a consensus target price of $114.13.

View Our Latest Research Report on ALB

Hedge Funds Weigh In On Albemarle

Hedge funds have recently added to or reduced their stakes in the company. Empower Advisory Group LLC lifted its holdings in Albemarle by 11.4% in the second quarter. Empower Advisory Group LLC now owns 866,575 shares of the specialty chemicals company’s stock valued at $54,308,000 after buying an additional 88,457 shares during the period. AXQ Capital LP bought a new stake in shares of Albemarle during the 2nd quarter valued at about $267,000. Bard Financial Services Inc. acquired a new stake in Albemarle during the second quarter worth approximately $1,850,000. Leibman Financial Services Inc. lifted its stake in Albemarle by 14.6% in the second quarter. Leibman Financial Services Inc. now owns 48,871 shares of the specialty chemicals company’s stock valued at $3,063,000 after buying an additional 6,237 shares during the period. Finally, Teza Capital Management LLC bought a new position in shares of Albemarle during the 1st quarter worth approximately $764,000. Institutional investors own 92.87% of the company’s stock.

Albemarle Stock Up 4.9%

The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.51 and a current ratio of 2.27. The firm’s 50 day moving average price is $110.19 and its two-hundred day moving average price is $86.71. The company has a market cap of $16.18 billion, a P/E ratio of -86.46 and a beta of 1.43.

Albemarle (NYSE:ALBGet Free Report) last issued its earnings results on Wednesday, November 5th. The specialty chemicals company reported ($0.19) EPS for the quarter, beating analysts’ consensus estimates of ($0.92) by $0.73. The business had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.27 billion. Albemarle had a positive return on equity of 0.10% and a negative net margin of 0.43%.The firm’s revenue was down 3.5% compared to the same quarter last year. During the same period in the previous year, the company posted ($1.55) EPS. Equities research analysts anticipate that Albemarle Corporation will post -0.04 EPS for the current fiscal year.

Albemarle Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 2nd. Investors of record on Friday, December 12th will be issued a $0.405 dividend. This represents a $1.62 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date is Friday, December 12th. Albemarle’s dividend payout ratio is currently -101.89%.

About Albemarle

(Get Free Report)

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

Further Reading

Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.